The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
The cancer cell biology contains in-depth information about the structure and function of normal cell and tumour cell. The cancer form series of molecular events that alter the properties of normal cells. The altered cells would divide and grow and the no longer required special signals to induce cell growth and division. As these cells grow they develop new characteristics including changes in cell structure, such changes make cancer cell to spread and invade other tissues. Thus it leads to detail understanding of process of tumorigenesis at the molecular level and created novel opportunities to specifically target the modified genes.
- Track 1-1Circadian Clocks & UPR
- Track 1-2Advancements And Challenges In EMT
- Track 1-3Role Of PERK
- Track 1-4Imaging Organoids
Tumour immunology is a branch of biology that deal with role of immune system in the progression and development of cancer. The tumour cells has a capacity to escape immune response by modulating the key target molecules. Tumour are infiltrated by a broad range of immune cell types which have distinct functions in Tumour Micro Environment (TME). The immune system will play a major role for tumourgenesis and metastasis. The immune response, including the recognition of cancer-specific antigens leads to development of targeted therapy and tumor marker-based diagnostic tests. Thus it lead to better understanding in manipulating immune system to fight against cancer.
- Track 2-1The Achilles Heel Of Cancer
- Track 2-2Mechanistic Insights
- Track 2-3Complement System In Cancer
- Track 2-4Role Of CD8+ T cell In Solid TME
Tumour immunotherapy is a therapy to treat cancer that involves or uses the components of immune system. In last few decades the immunotherapy has become important part in treating some types of cancer. Immunotherapy includes treatments which work in different ways. some therapies boost the body immune system, but other therapies will train the immune system to attack the cancer cells specifically. The success of these therapies illustrates the importance of careful decoding of basic immunology for successful clinical translation in treating cancer. It provides new insights into the mechanisms that underlie cancer immune evasion might lead to pathways for identifying novel and efficacious treatments.
- Track 3-1 Immune -Vascular Cross talk
- Track 3-2Solid Tumour Immunotherapy
- Track 3-3Role Of CircRNA
- Track 3-4Immune Checkpoints Inhibitors
- Track 3-5T-cell Based Immunotherapy
Metastasis is the complex series of step in which cancer cell leave the original tumour site and migrate to distant location in the body . Metastasis is the inefficient process. Most of the cancer cell will die during the process. It helps to determine staging and treatment. Angiogenesis is the critical step for cancer metastasis. The body resist metastasis by variety of mechanism through the action of class of proteins called "Metastasis Suppressor". Most tumour and neoplasm will metastasize. The degree of ability to metastasize varies between different types of cancers.For example, bladder cancer that metastasizes to the liver is not liver cancer. It is called metastatic bladder cancer.
- Track 4-1Tumour Adipose Tissue Cross Talk
- Track 4-2SOCE In Cancer Metastasis
- Track 4-3 Role Of DDR
- Track 4-4IL-1 & IL-2 Regulatory Pathway
The Cancer Metabolomics attempts to study all metabolism within a tumour cell which helps to analyze the cancer metabolism which includes a broad picture of altered pathway and their interaction with each other. The metabolic profile are mainly affected by environmental changes and therefore by directly measuring metabolites may provide epigenetically relevant information of cancer. The metabolomics research is used to obtain the mechanistic insights into cancer and also emerging in areas such as tumour staging and assessment of treatment efficacy.
- Track 5-1Pharmacometabolomics
- Track 5-2NMR Based Metabolomics
- Track 5-3Advancements In Cancer Metabolomics
- Track 5-4Desmoid Tumour
There are several methods for diagnosing cancer.With advanced technologies there is a rise number of diagnostic tools that will help to detect cancer. some of the cancers are hard to classify in such case second opinion is needed before being diagnosis. The treatment of cancer depend on the type of cancer. Cancer therapy describes treatment of cancer in a patient often with surgery or radiotherapy. Advanced therapies are also available for some type of cancer oncology immune-oncology treatments can be delivered using a variety of techniques and classes of agent such as Monoclonal antibodies, Small molecules etc..
- Track 6-1Dendritic Polymer Based Nano Material
- Track 6-2Multimodal Cancer Therapy
- Track 6-3Role Of Aptamers
- Track 6-4Nanotheranostics
- Track 6-5Radiotheranostics
Cancer stem cell play a important role in cancer initiation and progression. CSC characterized by self renewal and capacity to differentiate. The particular population of cancer stem cell are Mesenchymal stem cell they have potential pro and anti-tumourgenic properties and it is associated with tumorigenesis. The interaction between MSC's and cancer cell is the fundamental for metastasis and progression.The discovery of tumor stem cells in a range of cancers has created opportunities for researchers to identify rare cells in both solid tumors and hematologic cancers, as well as to investigate the role of these cells at different stages of disease.
- Track 7-1Role Of CD44 & CSC
- Track 7-2 ALDH Activity Assay
- Track 7-3 Therapeutic Potential Of MSC
- Track 7-4CSC In Tissue Generation
- Track 7-5 Clinical Oncology
Targeted Cell Therapy has long been as a cornerstone of medical therapies for maligancies. It targets the specific pathway in growth and development of tumour cell.Targeted Cell Therapy is favorable for rapidly dividing cells and maligant cells. This type of treatment is toxic for all type of cells.The targets are basically small molecules that play a major role in cancer formation. Many of the targets are tyrosine kinase that affects molecular signalling.
- Track 8-1TEM8/ANTXR1-Specific CAR T Cells
- Track 8-2Novel Carbonic Anhydrase IX
- Track 8-3Fluorogenic Reaction-Based Prodrug Conjugates
- Track 8-4 Transcriptional Repression
A new method to kill tumour cells called Capsase Independent Cell Death (CICD) that decrease the side effects and boost the host immune system to get rid of all tumour cells . A new emerging approach is called Adoptive Cell Transfer (ACT) that uses the own immune cells to treat cancer. There are several types of ACT one of the type has advanced in clinical development called as CAR T-cells. They are known as "living cells". They are the synthetic molecules. The CAR-T cells target CD19 that is a cell surface molecules for most leukemia and lymphomas.
- Track 9-1Caspase Independent Cell Death
- Track 9-2CAR-T Therapy (chimeric antigen receptor)
Artificial intelligence improves the accuracy of cancer diagnosis. A machine learning algorithm has been developed using deep learning approach which interprets complex pattern observed in real life data.It is used to make pathological diagnosis of cancer more accurate and predictive.It provide new insights into biophysics of cancer.
- Track 10-1Deep learning Algorithms
- Track 10-2Immunity - Machine Interface
- Track 10-3Cryptography Therapy
- Track 10-4Generative Adversarial Network
Cancer Biopsy involves taking of small sample of body tissue to investigate abnormalities and it is also used to asses the severity and grade. There are different types of biopsy procedure they are incisional biopsy,excisional biopsy and needle biopsy. when fine needle is used it is called as fine needle aspiration biopsy. In case of using wide needle it is called as core needle biopsy. Scientist have been exploring a new approach called as liquid biopsy it analyze the bits of tumor material molecule and a whole cell that are found in body fluids such as blood and urine.
- Track 11-1 Liquid Biopsy
- Track 11-2Optical Biopsy
- Track 11-3MRI Ultrasound Fusion Biopsy
- Track 11-4Streostatic Biopsy
Cancer Biomarker is a substance that indicate the presence of cancer in the body. It may be a substance that are secreted by the tumour or the specific response of the body in presence of cancer.The advancement in biomarker leads to discovery of new drug targets.The biomarker are found in variety of fluids , tissues and cell lines.The Biomarkers can be DNA, RNA, protein or metabolite. It helps to understand the drug metabolism,drug action,safety and efficacy. It also provide information about the disease type and it predict response to therapies.
- Track 12-1Serum Thymidine Kinase 1
- Track 12-2Platelet Protein
- Track 12-3CTC-derived AR-V7
- Track 12-4Assessment Of CTC
A combined discipline of medical oncology, which may be defined as the non-surgical, non-radiotherapeutic management of patients with solid tumours and clinical pharmacology, based on classic cytotoxic chemotherapy and the new signal transduction inhibitors. Cancer drug development is leading the way in exploiting molecular biological and genetic information to develop 'personalized' medicine. The new paradigm is to develop agents that target the precise molecular pathology driving the progression of individual cancers.
- Track 13-1Percision Medicine
- Track 13-2Tumour Associated Macrophages
- Track 13-3 Nanoparticle Based Delivery Systems
- Track 13-4Molecular Targeting
Recent advances in platform technologies and the increasing availability of biological 'big data' are providing an opportunity to systematically identify the key genes and pathways involved in tumorigenesis. The discoveries made using these new technologies may lead to novel therapeutic interventions. These approaches include the analysis of genomic sequencing data, pathway data, multi-platform data, identifying genetic interactions such as synthetic lethality and using cell line data. They revealed how big data is being used to identify novel drug targets.
- Track 14-1Tumour Agnostic Cancer Drugs
- Track 14-2Non Coding RNAs
- Track 14-3Cell Surface Proteomics
- Track 14-4 Oncogenic Transcription Factors By Polyphenols
The treatment for cancer is vacillating and dependent on a number of factors including the type, location and amount of disease, and the health status of the patient. Most treatments are designed to kill or remove the cancer cells and lead to their eventual death by depriving them from signals needed for survival. Other treatments work by stimulating the body's own immune system against the cancer cells.There are three general types of cancer treatments.They are radiation therapy, surgery and systemic therapy
- Track 15-1Next Generation Targeted Therapies
- Track 15-2DNA Cages
- Track 15-3Molecuar Cancer Diagnostics
- Track 15-4 Multifunctional Radiology
- Track 15-5Insilico Trials
A new advanced technology in cancer treatment is called ChemoID. In ChemoID, an oncologist has a chance of using the most effective chemotherapy drugs for a patient particular cancer. Through which it can determine which medicines kill the cells most effectively. There are many other advancements such as linear accelerator, Three dimensional conformal radiation therapy,IMRT,IMGT etc.. Advancements in technology have lessened much of that danger and made treatment into a safer, more effective form of treatment.
- Track 16-1Personalized Medicine And Cancer
- Track 16-2High Dosage Rate Brachytherapy
- Track 16-3Nanoparticles- A developing solution
- Track 16-4Three Dimensional Conformational Radiation Therapy
- Track 16-5IGRT
- Track 16-6IMRT
Cancer Epidemiology is a branch of science that deals with the cnacer distribution, incidence and prevention of disease and other factors related to health. The ultimate goal is to identify the major risk factors they may lead to effective preventive measures. It represents the study of factors responsible that are for the initiation, metastasis and prognosis of various types of cancer. Epidemiological research findings on cancer lead to the formulation of suitable therapeutic treatment methods and preventive medicines for cancer.
- Track 17-1Descriptive Epidemiology
- Track 17-2Global Cancer Incidence And Mortality
Cancer prevention and management is the measures taken to lower the chance of getting cancer. In addition to the physical and emotional problems caused by cancer, the high costs of care are also a burden to patients, their families, and to the public. By preventing cancer, the number of new cases of cancer is lowered. The risk can be reduced based on the Specific type of cancer. Reducing the risk of cancer may also be through dietary and lifestyle changes. Greater than 75% of cancer deaths could be prevented by avoiding risk factors including tobacco, obesity,an insufficient diet, physical inactivity, alcohol etc..
- Track 18-1Strategies
- Track 18-2Pain Management